首页|期刊导航|中国神经再生研究（英文版）|Cochlear amyloid beta 42-mediated hearing loss:A marker of preclinical Alzheimer's disease

Cochlear amyloid beta 42-mediated hearing loss:A marker of preclinical Alzheimer's disease

Dheyaa Al-Sallami Shelley Tischkau Raheem F.H.Al Aameri Leonard P.Rybak

中国神经再生研究（英文版）2026，Vol.21Issue(9)：4255-4256,2.

中国神经再生研究（英文版）2026，Vol.21Issue(9)：4255-4256,2.DOI:10.4103/NRR.NRR-D-25-01128

Cochlear amyloid beta 42-mediated hearing loss:A marker of preclinical Alzheimer's disease

Dheyaa Al-Sallami ¹Shelley Tischkau ¹Raheem F.H.Al Aameri ¹Leonard P.Rybak¹

作者信息

1. Department of Pharmacology,Southern Illinois University School of Medicine,Springfield,IL,USA
折叠

摘要

引用本文复制引用

Dheyaa Al-Sallami,Shelley Tischkau,Raheem F.H.Al Aameri,Leonard P.Rybak..Cochlear amyloid beta 42-mediated hearing loss:A marker of preclinical Alzheimer's disease[J].中国神经再生研究（英文版）,2026,21(9):4255-4256,2.

中国神经再生研究（英文版）

ISSN：1673-5374

访问量0

下载量0

段落导航